What Are the Benefits of DHEA Therapy for Addison's Disease?
At a Glance
DHEA may modestly improve mood and quality of life for some women with Addison's disease when standard steroid treatment is optimized, but results are mixed. It is an optional, monitored trial—not a replacement for hydrocortisone or fludrocortisone and it does not prevent adrenal crisis.
In this answer
4 sections
CRITICAL SAFETY WARNING: DHEA is an optional treatment and must never replace, reduce, or be used instead of your life-saving glucocorticoid (e.g., hydrocortisone) or mineralocorticoid (e.g., fludrocortisone) medications [1]. DHEA cannot treat or prevent an adrenal crisis. You must continue your standard steroid schedule, sick-day rules, and emergency-injection plans. Never self-start over-the-counter DHEA products, as formulations vary widely; any trial must be strictly managed by your endocrinologist [2].
DHEA (dehydroepiandrosterone) replacement therapy is an optional, clinician-supervised treatment for Addison’s disease that may offer modest improvements in mood and overall quality of life, primarily for carefully selected women [3]. Unlike cortisol and aldosterone, DHEA is not essential for life and is not routinely prescribed [1][2]. It is sometimes trialed when patients experience persistent fatigue, low mood, or low libido even after their standard hormone replacement is fully reviewed and optimized [1][2].
The Role of DHEA in the Body
DHEA is a hormone naturally produced by the adrenal glands [1]. It functions as a proandrogen, meaning it is a precursor that the body converts into active sex hormones, including androgens (like testosterone) and estrogens [3].
In primary adrenal insufficiency (Addison’s disease), the damaged adrenal glands stop making DHEA, leading to a severe drop in blood levels [4]. While the ovaries and testicles also produce sex hormones, the adrenal glands contribute a substantial portion of the body’s androgen supply in many women. This is why evidence for DHEA trials focuses mainly on women with primary adrenal insufficiency, though individual needs depend on age, gonadal function, and menopause status [2].
Signs You Might Benefit from a Trial
Because DHEA is not a life-sustaining hormone, major medical guidelines do not recommend it as a standard treatment for everyone [2]. Instead, an endocrinologist might offer it as an individualized trial [5].
You and your doctor might consider a trial of DHEA if you are experiencing the following symptoms, despite having optimized doses of your standard medications:
- Persistent low energy [1]
- Low mood or a generally reduced sense of well-being [3]
- Loss of libido (sex drive) [2]
(Note: Some patients report dry skin, but this is a nonspecific symptom that often points to dehydration, eczema, or thyroid issues rather than a proven need for DHEA [6].)
What the evidence says: It is important to have realistic expectations. DHEA is not a reliable treatment for clinical depression, severe anxiety, or extreme fatigue [3]. Clinical trials show that while DHEA may provide modest improvements in mood and quality of life for some women, results are mixed, and it does not consistently improve sexual function [3][2]. Simply having a low DHEA-S blood test result is not a reason to take the supplement if you are otherwise feeling well [4].
Before starting DHEA, your doctor should evaluate you for other causes of your symptoms. Persistent fatigue often stems from poor sleep, thyroid disease, anemia, or an unsuitable hydrocortisone dosing schedule [7].
What a Supervised Trial Looks Like
Because long-term safety data is limited, DHEA is usually given as a time-limited trial—commonly for six months [2]. A standard trial involves:
- Baseline Review: Confirming your hydrocortisone and fludrocortisone doses are optimized and ruling out other medical conditions [7].
- Setting Goals: Agreeing on which specific symptoms you want to improve and establishing a strict review timeline [2].
- Monitoring: Checking baseline and follow-up blood levels of DHEA-S to ensure you stay within an age-appropriate physiological range, rather than just aiming to raise the number [2]. Depending on your risk factors, your doctor may also check your lipid (cholesterol) profile, as high doses of DHEA can lower HDL (the “good” cholesterol) [8].
- Stopping Date: If you do not feel a clear, meaningful clinical improvement by the end of the trial period, your doctor will likely recommend stopping the medication to avoid unnecessary risks [2].
Safety and Potential Side Effects
Because DHEA converts into androgens and estrogens, it must be used with caution—or avoided entirely—if you are pregnant, breastfeeding, trying to conceive, or have a history of hormone-sensitive cancers or blood clots [9].
If your dose is too high, DHEA can cause androgenic (male-hormone-like) side effects. These can include:
- Acne or very oily skin [3][10]
- Scalp hair loss [11]
- Unwanted facial or body hair growth (hirsutism) [1]
- Changes to your menstrual cycle [11]
Virilizing effects: In rare cases or with excessive doses, DHEA can cause irreversible virilizing changes, such as voice deepening or clitoral enlargement [3]. If you notice rapidly increasing facial hair, voice changes, or severe acne, contact your endocrinologist promptly.
Common questions in this guide
What benefits can DHEA provide in Addison's disease?
Can DHEA replace hydrocortisone or fludrocortisone?
Who might be a candidate for a DHEA trial?
How is DHEA replacement monitored?
What side effects can DHEA cause?
Who should avoid DHEA or discuss extra risks before taking it?
Is over-the-counter DHEA safe to start on my own?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are my current hydrocortisone and fludrocortisone doses fully optimized, and what other conditions should we rule out before considering DHEA?
- 2.If we start a trial of DHEA, what specific symptom improvements will define success for us?
- 3.What specific side effects or symptoms should make me stop taking DHEA and contact you immediately?
- 4.How frequently will you monitor my DHEA-S levels and cholesterol during this trial?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency.
Handelsman DJ, Matsumoto AM, Gerrard DF
Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 2017; (27(1)):78-85 doi:10.1097/JSM.0000000000000300.
PMID: 26844622 - 2
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency.
Bennett G, Cussen L, O'Reilly MW
Current opinion in endocrinology, diabetes, and obesity 2022; (29(3)):284-293 doi:10.1097/MED.0000000000000728.
PMID: 35621180 - 3
Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K
The Journal of clinical endocrinology and metabolism 2022; (107(6)):1679-1685 doi:10.1210/clinem/dgac130.
PMID: 35254428 - 4
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions.
Heald AH, Walther A, Davis JRE, et al.
Frontiers in psychology 2017; (8()):764 doi:10.3389/fpsyg.2017.00764.
PMID: 28553251 - 5
SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.
Reznik Y, Barat P, Bertherat J, et al.
Annales d'endocrinologie 2018; (79(1)):1-22 doi:10.1016/j.ando.2017.12.001.
PMID: 29338844 - 6
Potential prevention by oral DHEA of superficial tears in elderly atrophic skin.
Daniell HW
The Journal of steroid biochemistry and molecular biology 2017; (171()):155-156 doi:10.1016/j.jsbmb.2017.03.007.
PMID: 28300625 - 7
Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
Petersen KS, Rushworth RL, Clifton PM, Torpy DJ
BMC endocrine disorders 2015; (15()):61 doi:10.1186/s12902-015-0058-6.
PMID: 26500000 - 8
Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.
Qin Y, O Santos H, Khani V, et al.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2020; (30(9)):1465-1475 doi:10.1016/j.numecd.2020.05.015.
PMID: 32675010 - 9
Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase.
Sauer U, Talaulikar V, Davies MC
Maturitas 2018; (116()):79-82 doi:10.1016/j.maturitas.2018.07.016.
PMID: 30244783 - 10
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
Scheffers CS, Armstrong S, Cantineau AE, et al.
The Cochrane database of systematic reviews 2015; (1()):CD011066 doi:10.1002/14651858.CD011066.pub2.
PMID: 25879093 - 11
Androgen deficiency in hypopituitary women: its consequences and management.
Esposito D, Tivesten Å, Olivius C, et al.
Reviews in endocrine & metabolic disorders 2024; (25(3)):479-488 doi:10.1007/s11154-024-09873-1.
PMID: 38240912
This page is for informational purposes only and does not constitute medical advice. Do not start DHEA or change hydrocortisone or fludrocortisone without guidance from your endocrinologist.
Get notified when new evidence is published on Chronic primary adrenal insufficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.